Evidence map›Paper›PMID 40639854›Full record

Trial reportBMJ global health2025

Hypertensive disorders of pregnancy and perinatal outcomes: two prospective cohort studies of nulliparous women in India and Tanzania.

Andrea B Pembe, Pratibha Dwarkanath, Amani Kikula, John Michael Raj, Nandita Perumal, Heavenlight A Paulo, Rajalakshmi M, Christopher P Duggan, Honorati M Masanja, Nandini Chopra and 8 more

Registry-linked trialAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03350516 (Demonstrating Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy for Reducing Preeclampsia and Neonatal Outcomes), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03350516 phase3completednot on this map

Demonstrating Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy for Reducing Preeclampsia and Neonatal Outcomes

TypeinterventionalSponsorHarvard School of Public Health (HSPH)Ran2018 to 2022Enrolled22,000ConditionsPregnancy RelatedArmsDaily 500 mg elemental calcium as calcium carbonate, Daily1500 mg elemental calcium as calcium carbonate
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Andrea B PembeMuhimbili University of Health and Allied Sciences, Dar es Salaam, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0002-8090-3298
Pratibha DwarkanathSt John's Research Institute, Bangalore, Karnataka, India.
Amani KikulaMuhimbili University of Health and Allied Sciences, Dar es Salaam, Dar es Salaam, Tanzania, United Republic of.
John Michael RajSt John's Medical College, Bangalore, Karnataka, India.
Nandita PerumalHarvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Heavenlight A PauloMuhimbili University of Health and Allied Sciences, Dar es Salaam, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0002-3162-9982
Rajalakshmi MSt John's Research Institute, Bangalore, Karnataka, India.
Christopher P DugganHarvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Honorati M MasanjaIfakara Health Institute, Dar es Salaam, Tanzania, United Republic of.
Nandini ChopraSt John's Research Institute, Bangalore, Karnataka, India.
Mary M SandoAfrica Academy for Public Health, Dar es Salaam, Tanzania, United Republic of.
Tinku ThomasSt John's Medical College, Bangalore, Karnataka, India.
Cara A YelvertonHarvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Alfa MuhihiAfrica Academy for Public Health, Dar es Salaam, Tanzania, United Republic of.
Anura V KurpadSt John's Medical College, Bangalore, Karnataka, India.
Wafaie W FawziHarvard T H Chan School of Public Health, Boston, Massachusetts, USA.
Blair J WylieBeth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Christopher R SudfeldHarvard T H Chan School of Public Health, Boston, Massachusetts, USA csudfeld@hsph.harvard.edu.ORCID http://orcid.org/0000-0002-3203-3638

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
NIDDK NIH HHS P30 DK040561
6 · The paper itself

Abstract

introductionHypertensive disorders of pregnancy (HDP) have been linked with increased risk for maternal and offspring complications in high-income settings. However, in resource-limited settings, studies with robust measurement of HDP, including severity and timing, and perinatal outcomes are limited.

methodsWe analysed data from two prospective cohorts of nulliparous women in India (n=10 570 pregnancies) and Tanzania (n=10 299 pregnancies) who were enrolled in calcium supplementation trials and had blood pressure and proteinuria assessments throughout pregnancy and at the time of labour and delivery. Generalised estimating equations were used to assess the relationship between HDP severity categories (gestational hypertension, preeclampsia without severe features and preeclampsia with severe features) and timing of HDP onset (early-onset <34 weeks vs late-onset ≥34 weeks gestation) with adverse perinatal outcomes.

resultsThe cumulative incidence of HDP was 3.7% and 4.5% in the India and Tanzania cohorts, respectively. All HDP severity categories were associated with a significantly higher risk for perinatal death in both cohorts (p values<0.05). Pregnancies complicated by pre-eclampsia with severe features had the largest magnitude of increased risk for perinatal death as compared with pregnancies without an HDP (India RR 8.60; 95% CI 5.90 to 12.53; Tanzania RR 4.05; 95% CI 2.91 to 5.66). In both cohorts, pre-eclampsia with and without severe features, but not gestational hypertension, was associated with increased risks for preterm birth and low birth weight. Pregnancies with early-onset HDP had a high absolute risk of perinatal death (India 25.6% and Tanzania 36.9%), and the risk was markedly increased as compared with late-onset HDP (India RR 4.79; 95% CI 2.68 to 8.54; Tanzania RR 5.79; 95% CI 3.56 to 9.41).

conclusionHDP were differentially associated with risks for perinatal outcomes by severity and timing of onset. Interventions that prevent, reduce the severity or delay the onset of HDP may improve perinatal outcomes in resource-limited settings. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov number, NCT03350516.

Indexed as

Hypertension, Pregnancy-InducedPregnancy OutcomeAdultFemaleHumansIncidenceIndiaInfant, NewbornParityPre-EclampsiaPregnancyProspective StudiesRisk FactorsTanzaniaYoung AdultChild healthCohort studyHypertensionObstetrics

Identifiers

PMID40639854
PMCPMC12258372

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.